테라반스바이오파마(주)
US ˙ NasdaqGM ˙ KYG8807B1068

SecurityTBPH / Theravance Biopharma, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership950 shares
Latest Disclosed Value $ 17,774
Group One Trading, L.p. ownership in TBPH / Theravance Biopharma, Inc.

On February 11, 2026 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 950 shares of Theravance Biopharma, Inc. (US:TBPH) valued at $17,774 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 316 shares of Theravance Biopharma, Inc.. This represents a change in shares of 200.63% during the quarter. The current value of the position is $15,476 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (TBPH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TBPH / Theravance Biopharma, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 950 634 200.63 18 325.00 0.0000
2025-11-12 2025-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 316 316 5 0.0000
2023-11-09 2023-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 0 -3,069 -100.00 0 -100.00
2023-08-09 2023-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 3,069 -543 -15.03 32 -20.51 0.0001
2023-05-12 2023-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 3,612 3,612 39 0.0001
2023-02-09 2022-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 0 -3,608 -100.00 0 -100.00
2022-11-09 2022-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 3,608 1,933 115.40 37 146.67 0.0001
2022-08-11 2022-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 1,675 -7,000 -80.69 15 -81.93 0.0000
2022-05-12 2022-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 8,675 -36,330 -80.72 83 -83.30 0.0001
2022-02-11 2021-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 45,005 -20,053 -30.82 497 3.33 0.0004
2021-11-12 2021-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 65,058 65,058 481 0.0005
2020-05-12 2020-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 0 -637 -100.00 0 -100.00
2020-02-10 2019-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 637 -16,100 -96.19 16 -95.09 0.0001
2019-11-12 2019-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 16,737 -42,831 -71.90 326 -66.50 0.0026
2019-08-09 2019-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 59,568 47,991 414.54 973 271.37 0.0088
2019-05-14 2019-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 11,577 11,577 -80.57 262 -73.07 0.0029
2019-05-13 2019-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 11,577 11,577 262
2018-08-13 2018-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 0 -1,100 -100.00 0 -100.00
2018-05-16 2018-03-31 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 1,100 1,100 27 0.0003
2018-05-10 2018-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 1,100 1,100 27
2018-02-09 2017-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 0 -3,500 -100.00 0 -100.00
2017-11-15 2017-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 3,500 3,500 120 0.0011
2017-02-15 2016-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 0 -1,377 -100.00 0 -100.00
2016-11-14 2016-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 1,377 1,377 0.00 50 0.0005
2016-08-12 2016-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 0 -2,912 -100.00 0 -100.00
2016-05-12 2016-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 2,912 -600 -17.08 55 -5.17 0.0008
2016-02-11 2015-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 3,512 -43,772 -92.57 58 -88.85 0.0007
2015-11-20 2015-09-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 47,284 47,284 1,246.36 520 796.55 0.0072
2015-11-06 2015-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 47,284 520
2015-08-11 2015-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 0 -581 -100.00 0 -100.00
2015-05-14 2015-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 581 581 0.00 10 0.0002
2015-02-11 2014-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 0 -2,093 -100.00 0 -100.00
2014-10-31 2014-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 2,093 -1,428 -40.56 48 -57.14 0.0007
2014-08-12 2014-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 3,521 3,521 112 0.0017
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F THERAVANCE BIOPHARMA COM Call 900 200.00 13 333.33 n/a n/a n/a
2025-08-14 2025-06-30 13F THERAVANCE BIOPHARMA COM Call 300 3 n/a n/a n/a
2025-05-14 2025-03-31 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A THERAVANCE BIOPHARMA COM Call 600 0.00 6 25.00 n/a n/a n/a
2024-11-14 2024-09-30 13F THERAVANCE BIOPHARMA COM Call 600 5 n/a n/a n/a
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 n/a n/a n/a
2024-05-10 2024-03-31 13F THERAVANCE BIOPHARMA COM Call 100 -99.22 1 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F THERAVANCE BIOPHARMA COM Call 12,800 509.52 144 694.44 n/a n/a n/a
2023-11-09 2023-09-30 13F THERAVANCE BIOPHARMA COM Call 2,100 600.00 18 500.00 n/a n/a n/a
2023-08-09 2023-06-30 13F THERAVANCE BIOPHARMA COM Call 300 -97.06 3 -97.27 n/a n/a n/a
2023-05-12 2023-03-31 13F THERAVANCE BIOPHARMA COM Call 10,200 -87.97 111 -88.43 n/a n/a n/a
2023-02-09 2022-12-31 13F THERAVANCE BIOPHARMA COM Call 84,800 315.69 951 359.42 n/a n/a n/a
2022-11-09 2022-09-30 13F THERAVANCE BIOPHARMA COM Call 20,400 119.35 207 146.43 n/a n/a n/a
2022-08-11 2022-06-30 13F THERAVANCE BIOPHARMA COM Call 9,300 520.00 84 500.00 n/a n/a n/a
2022-05-12 2022-03-31 13F THERAVANCE BIOPHARMA COM Call 1,500 -93.36 14 -94.40 n/a n/a n/a
2022-02-11 2021-12-31 13F THERAVANCE BIOPHARMA COM Call 22,600 -78.52 250 -67.87 n/a n/a n/a
2021-11-12 2021-09-30 13F THERAVANCE BIOPHARMA COM Call 105,200 778 n/a n/a n/a
2021-08-10 2021-06-30 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-12 2021-03-31 13F THERAVANCE BIOPHARMA COM Call 1,100 -71.79 225 226.09 n/a n/a n/a
2021-02-10 2020-12-31 13F THERAVANCE BIOPHARMA COM Call 3,900 254.55 69 -69.33 n/a n/a n/a
2020-11-12 2020-09-30 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F THERAVANCE BIOPHARMA COM Call 200 -97.30 4 -97.66 n/a n/a n/a
2020-05-13 2020-03-31 13F THERAVANCE BIOPHARMA COM Call 7,400 393.33 171 338.46 n/a n/a n/a
2020-02-10 2019-12-31 13F THERAVANCE BIOPHARMA COM Call 1,500 -40.00 39 -20.41 n/a n/a n/a
2019-11-12 2019-09-30 13F THERAVANCE BIOPHARMA COM Call 2,500 -56.14 49 -47.31 n/a n/a n/a
2019-08-09 2019-06-30 13F THERAVANCE BIOPHARMA COM Call 5,700 128.00 93 89.80 n/a n/a n/a
2019-02-05 2018-12-31 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F THERAVANCE BIOPHARMA COM Call 3,100 101 n/a n/a n/a
2018-02-09 2017-12-31 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F THERAVANCE BIOPHARMA COM Call 5,300 181 n/a n/a n/a
2017-05-10 2017-03-31 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-15 2016-12-31 13F THERAVANCE BIOPHARMA COM Call 25,000 233.33 797 193.01 n/a n/a n/a
2016-11-14 2016-09-30 13F THERAVANCE BIOPHARMA COM Call 7,500 -70.00 272 -65.87 n/a n/a n/a
2016-08-12 2016-06-30 13F THERAVANCE BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-12 2016-03-31 13F THERAVANCE BIOPHARMA COM Call 10,200 920.00 192 1,100.00 n/a n/a n/a
2016-02-11 2015-12-31 13F THERAVANCE BIOPHARMA COM Call 1,000 150.00 16 300.00 n/a n/a n/a
2015-11-20 2015-09-30 13F/A THERAVANCE BIOPHARMA COM Call 400 100.00 4 33.33 n/a n/a n/a
2015-11-06 2015-09-30 13F THERAVANCE BIOPHARMA COM Call 400 4 n/a n/a n/a
2015-08-11 2015-06-30 13F THERAVANCE BIOPHARMA COM Call 200 -71.43 3 -75.00 n/a n/a n/a
2015-05-14 2015-03-31 13F THERAVANCE BIOPHARMA COM Call 700 12 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-12 2025-09-30 13F THERAVANCE BIOPHARMA COM Put 7,300 107 n/a n/a n/a
2024-08-14 2024-06-30 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-10 2024-03-31 13F THERAVANCE BIOPHARMA COM Put 200 2 n/a n/a n/a
2023-11-09 2023-09-30 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-09 2023-06-30 13F THERAVANCE BIOPHARMA COM Put 1,300 -35.00 13 -38.10 n/a n/a n/a
2023-05-12 2023-03-31 13F THERAVANCE BIOPHARMA COM Put 2,000 81.82 22 75.00 n/a n/a n/a
2023-02-09 2022-12-31 13F THERAVANCE BIOPHARMA COM Put 1,100 -94.69 12 -94.29 n/a n/a n/a
2022-11-09 2022-09-30 13F THERAVANCE BIOPHARMA COM Put 20,700 20,600.00 210 20,900.00 n/a n/a n/a
2022-08-11 2022-06-30 13F THERAVANCE BIOPHARMA COM Put 100 -99.12 1 -99.08 n/a n/a n/a
2022-05-12 2022-03-31 13F THERAVANCE BIOPHARMA COM Put 11,400 109 n/a n/a n/a
2022-02-11 2021-12-31 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F THERAVANCE BIOPHARMA COM Put 74,500 551 n/a n/a n/a
2020-08-13 2020-06-30 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F THERAVANCE BIOPHARMA COM Put 5,000 150.00 116 123.08 n/a n/a n/a
2020-02-10 2019-12-31 13F THERAVANCE BIOPHARMA COM Put 2,000 -97.40 52 -95.85 n/a n/a n/a
2019-08-09 2019-06-30 13F THERAVANCE BIOPHARMA COM Put 76,800 53.60 1,254 10.58 n/a n/a n/a
2019-05-14 2019-03-31 13F/A THERAVANCE BIOPHARMA COM Put 50,000 -34.90 1,134 -9.57 n/a n/a n/a
2019-05-13 2019-03-31 13F THERAVANCE BIOPHARMA COM Put 50,000 1,134 n/a n/a n/a
2018-08-13 2018-06-30 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-16 2018-03-31 13F/A THERAVANCE BIOPHARMA COM Put 200 5 n/a n/a n/a
2018-05-10 2018-03-31 13F THERAVANCE BIOPHARMA COM Put 200 5 n/a n/a n/a
2018-02-09 2017-12-31 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-15 2017-09-30 13F THERAVANCE BIOPHARMA COM Put 4,300 147 n/a n/a n/a
2017-05-10 2017-03-31 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-15 2016-12-31 13F THERAVANCE BIOPHARMA COM Put 2,500 -85.38 80 -87.10 n/a n/a n/a
2016-11-14 2016-09-30 13F THERAVANCE BIOPHARMA COM Put 17,100 388.57 620 684.81 n/a n/a n/a
2016-08-12 2016-06-30 13F THERAVANCE BIOPHARMA COM Put 3,500 -79.53 79 -87.26 n/a n/a n/a
2016-02-11 2015-12-31 13F THERAVANCE BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-11-20 2015-09-30 13F/A THERAVANCE BIOPHARMA COM Put 90,000 7,400.00 989 6,081.25 n/a n/a n/a
2015-11-06 2015-09-30 13F THERAVANCE BIOPHARMA COM Put 90,000 989 n/a n/a n/a
2015-08-11 2015-06-30 13F THERAVANCE BIOPHARMA COM Put 1,200 16 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.